Axena Health Raises $9.4M in Funding for Female Pelvic Health Solutions

Axena Health's Series A Funding

Key Highlights:

• Series A Funding: Additional $9.4 million raised in Series A funding.
• Investors: Cross-Border Impact Ventures (CBIV), AXA IM Alts, KOFA Healthcare, and Avestria Ventures.
• Focus on Female Pelvic Health: Axena Health is a medical device company dedicated to improving the lives of women with pelvic floor disorders.
• Flagship Product: Leva® Pelvic Health System offers non-invasive, drug-free treatment for urinary incontinence and chronic fecal incontinence.

Axena Health's Target Market

• Target Market: Women suffering from pelvic floor disorders, specifically urinary incontinence and chronic fecal incontinence.
• Healthcare Providers: Gynecologists, urologists, and other healthcare professionals specializing in female pelvic health.
• Healthcare Systems and Institutions: Hospitals, clinics, and women's health centers seeking innovative solutions for pelvic floor disorders.

What Axena Health Needs to Buy

• Research and Development: Investments in R&D to enhance and expand their product offerings for female pelvic health.
• Manufacturing and Supply Chain Solutions: Partnerships with manufacturers to ensure efficient production and distribution of their medical devices.
• Marketing and Sales Support: Collaborations with marketing agencies and sales experts to effectively reach their target market and healthcare providers.